Literature DB >> 24259140

CXCR7 influences the migration of B cells during maturation.

Marie-Luise Humpert1, Dora Pinto, David Jarrossay, Marcus Thelen.   

Abstract

The atypical chemokine receptor CXCR7 binds the chemokines CXCL12 and CXCL11. The receptor is widely expressed and was shown to tune CXCR12-induced responses of CXCR4. Here, the function of CXCR7 was examined at late stages of human B-cell maturation, when B cells differentiate into Ab-secreting plasmablasts. We identified two populations of CXCR7(+) cells in tonsillar lymphocytes, one being presumably memory B cells or early plasmablasts (FSC(low) CD19(+) CD38(mid) ) and the other being plasmablasts or early plasma cells (FSC(high) CD19(+) CD38(+) ). CXCR7 is expressed on CD19(+) CD27(+) memory B cells, on CD19(+) CD38(+) CD138(-) and intracellular immunoglobulin high plasmablasts, but not on CD19(+) CD138(+) icIg(high) plasma cells. The differential expression pattern suggests a potential contribution of the scavenger receptor in final B-cell maturation. On in vitro differentiating B cells, we found a marked inverse correlation between CXCR7 and CXCR5 cell surface levels, whereas expression of CXCR4 remained almost constant. Migration assays performed with tonsillar mononuclear cells or in vitro differentiated cells revealed that inhibition of CXCR7 markedly increases chemotaxis toward CXCL12, especially at late stages of B-cell maturation. Chemotaxis was attenuated in the presence of CXCR4 antagonists, confirming that migration is CXCR4 mediated. Our findings unequivocally demonstrate a novel role for CXCR7 in regulating the migration of plasmablasts during B-cell maturation.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Atypical chemokine receptor; B cells; CXCR4; CXCR5; CXCR7

Mesh:

Substances:

Year:  2014        PMID: 24259140     DOI: 10.1002/eji.201343907

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency.

Authors:  Susanne Unger; Maximilian Seidl; Annette Schmitt-Graeff; Joachim Böhm; Klaudia Schrenk; Claudia Wehr; Sigune Goldacker; Ruth Dräger; Barbara C Gärtner; Paul Fisch; Martin Werner; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2014-05-02       Impact factor: 8.317

2.  Editorial: Gateway to monocyte entry into the brain: CXCR7, the new orchestra conductor.

Authors:  Steven D Douglas; Sergei Spitsin
Journal:  J Leukoc Biol       Date:  2017-11       Impact factor: 4.962

Review 3.  Germinal Center-Related G Protein-Coupled Receptors in Antibody-Mediated Autoimmune Skin Diseases: from Basic Research to Clinical Trials.

Authors:  Pengpeng Cao; Ming Yang; Christopher Chang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-08       Impact factor: 8.667

4.  C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer.

Authors:  Junjie Xing; Xu Li; Jinke Sui; Guangwen Cao; Chuangang Fu
Journal:  Tumour Biol       Date:  2014-05-16

Review 5.  G-protein coupled receptors and ligands that organize humoral immune responses.

Authors:  Erick Lu; Jason G Cyster
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

6.  CXCR7/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells.

Authors:  Thomas D'huys; Sandra Claes; Tom Van Loy; Dominique Schols
Journal:  Heliyon       Date:  2018-03-01

7.  Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.

Authors:  Emmanuel Dotsey; Irina Ushach; Egest Pone; Rie Nakajima; Algis Jasinskas; Donovan A Argueta; Andrea Dillon; Nicholas DiPatrizio; Huw Davies; Albert Zlotnik; Peter D Crompton; Philip L Felgner
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

8.  Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation.

Authors:  Sung-Tai Wei; Yen-Chih Huang; Jung-Ying Chiang; Chia-Ching Lin; Yu-Jung Lin; Woei-Cherng Shyu; Hui-Chen Chen; Chia-Hung Hsieh
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

Review 9.  New insights in chemokine signaling.

Authors:  Daniel F Legler; Marcus Thelen
Journal:  F1000Res       Date:  2018-01-23

10.  ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration.

Authors:  Viola Puddinu; Sabrina Casella; Egle Radice; Sylvia Thelen; Stefan Dirnhofer; Francesco Bertoni; Marcus Thelen
Journal:  Oncotarget       Date:  2017-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.